




Searching News Database: MC-1
HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 15 Sep 2011
A Unique Treatment for Recurrent Mitral Regurgitation Eliminates the Need for High Risk Redo Surgery
A Unique Treatment for Recurrent Mitral Regurgitation Eliminates the Need for High Risk Redo Surgery
HSMN NewsFeed - 7 Sep 2011
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
HSMN NewsFeed - 20 Sep 2007
Medicure Announces Completion of Enrollment in Pivotal Phase 3 MEND-CABG II Trial
Medicure Announces Completion of Enrollment in Pivotal Phase 3 MEND-CABG II Trial
HSMN NewsFeed - 27 Jul 2007
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
Positive Aggrastat(R) Results Versus Integrilin(R) Featured in American Heart Journal
HSMN NewsFeed - 12 Dec 2006
Medicure Announces Special Protocol Assessment With the FDA For Phase III MEND-CABG II Study
Medicure Announces Special Protocol Assessment With the FDA For Phase III MEND-CABG II Study
HSMN NewsFeed - 14 Nov 2006
Medicure Announces New AGGRASTAT(R) Data at 2006 Scientific Sessions of the American Heart Association
Medicure Announces New AGGRASTAT(R) Data at 2006 Scientific Sessions of the American Heart Association
HSMN NewsFeed - 16 Aug 2006
Medicure Announces Clinical Agreement with Duke and Montreal Heart Institute on Phase III MC-1 Study
Medicure Announces Clinical Agreement with Duke and Montreal Heart Institute on Phase III MC-1 Study
Additional items found! 9

Members Archive contains
9 additional stories matching:
MC-1
(Password required)
MC-1
(Password required)